Miramontes Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Miramontes Capital's BMY Position: Q2 2026 in Review
Miramontes Capital increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, buying an estimated $6.6K and bringing the position to 5,715 shares worth $329K. The position accounts for 0.1% of the portfolio, ranked #107.
Miramontes Capital first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $340K in Q1 2026. 2,528 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Miramontes Capital held 5,715 shares of Bristol-Myers Squibb worth $329K as of Q2 2026.
- Miramontes Capital bought 115 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.6K.
- Bristol-Myers Squibb made up 0.1% of Miramontes Capital's portfolio in Q2 2026, its #107 holding.
- Miramontes Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Miramontes Capital's Bristol-Myers Squibb position peaked at $340K in Q1 2026.
- 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Miramontes Capital's 13F filing for Q2 2026, filed 9 Sep 2026.